Roth MKM lowered the firm’s price target on CervoMed (CRVO) to $4 from $45 and keeps a Buy rating on the shares. The company ...

Roth MKM raised the firm’s price target on IREN (IREN) to $25 from $20 and keeps a Buy rating on the shares following the ...

We recently compiled a list of the 11 AI News You Should Not Miss. In this article, we are going to take a look at where ...

Roth MKM analyst Mike Niehuser maintained a Buy rating on Solitario Exploration & Royalty (XPL – Research Report) yesterday and set a price ...

Fintel reports that on December 11, 2024, Roth MKM initiated coverage of Bloom Energy (NYSE:BE) with a Neutral recommendation ...

Roth MKM last night initiated coverage of Powell (POWL) with a Buy rating and $312 price target The firm believes a higher than historical ...

Yext (NYSE:YEXT – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at Roth Mkm in a report released on Tuesday,Benzinga reports. They presently have a $10.50 target ...

Roth MKM analyst Boobalan Pachaiyappan last night initiated coverage of Gain Therapeutics (GANX) with a Buy rating and $7 price target The firm says GT-02287, a potential $4B drug that ...

Roth MKM lowered the firm’s price target to $16, while keeping a Buy rating on the shares as revenues miss on direct-to-consumer mix shift. Roth notes that the company was again light on ...

Kroger (NYSE:KR – Free Report) had its target price upped by Roth Mkm from $52.00 to $56.00 in a research note issued to ...

Brokerage Roth MKM on Monday upgraded shares of Tesla (NASDAQ:TSLA) to Buy from Neutral, arguing that Elon Musk's "authentic support" for Donald Trump likely doubled the EV giant's pool of ...

We recently compiled a list of the 15 AI News and Ratings Trending on Financial Media. In this article, we are going to take ...